Eris Lifesciences partnership with Natco Pharma for Semaglutide launch in India
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
Bocunebart works by blocking pituitary adenylate cyclase-activating polypeptide
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
KEYTRUDA QLEX is contraindicated in patients with known hypersensitivity to its components
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
The new OMR facility, located in Chennai’s medical hub, is close to leading hospitals and offers excellent road and air connectivity
Subscribe To Our Newsletter & Stay Updated